Table: Delta-Fly Pharma - Q1 parent results

Delta-Fly Pharma

14/08/2020 06:30

Aug 14 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Jun 30, 2020        Jun 30, 2019       Mar 31, 2021  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales                                                  300 mln     
                                                       (+200.0 pct)  
  Operating     loss 253 mln        loss 216 mln       loss 850 mln  
  Recurring     loss 253 mln        loss 218 mln       loss 850 mln  
  Net           loss 253 mln        loss 219 mln       loss 850 mln  
  EPS          loss 56.37 yen      loss 50.15 yen    loss 188.70 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T